We are your trusted health partner. Local doorstep deliveries is within the hour .We are Licensed and Regulated by the Pharmacist's Council of Nigeria(PCN).Prices displayed here may differ due to inflation.

    0    

We are your trusted health partner. Local doorstep deliveries is within the hour .We are Licensed and Regulated by the Pharmacist's Council of Nigeria(PCN).Prices displayed here may differ due to inflation.

CONJUGATE MENINGITIS VACCINE MENACTRA

Category: VACCINES

CONJUGATE MENINGITIS VACCINE MENACTRA

₦52,500 ₦63,000

Description:

Menactra is a high-purity, quadrivalent conjugate vaccine designed to protect against four major groups of Neisseria meningitidis: A, C, W-135, and Y. It works through a protein-conjugation mechanism: the bacterial polysaccharides (sugars) are chemically linked to a diphtheria toxoid protein carrier. This "conjugation" allows the vaccine to trigger a much stronger and longer-lasting immune memory than older polysaccharide vaccines, even in young children, effectively preventing life-threatening meningitis and rapid-onset sepsis.

Manufacturer: Sanofi Pasteur (France/Global)

Quantity:

MENACTRA (MENINGOCOCCAL CONJUGATE VACCINE) – QUADRIVALENT ACWY PROTECTION

Menactra is a high-purity, quadrivalent conjugate vaccine designed to protect against four major groups of Neisseria meningitidis: A, C, W-135, and Y. It works through a protein-conjugation mechanism: the bacterial polysaccharides (sugars) are chemically linked to a diphtheria toxoid protein carrier. This "conjugation" allows the vaccine to trigger a much stronger and longer-lasting immune memory than older polysaccharide vaccines, even in young children, effectively preventing life-threatening meningitis and rapid-onset sepsis.

In Nigeria, Menactra (by Sanofi Pasteur) is the "gold standard" for protecting students, travelers, and pilgrims against the various strains circulating in the "African Meningitis Belt." It is available through specialized travel clinics and registered pharmacies like Sanlive Pharmacy, ensuring you receive authentic, laboratory-verified vials stored in strict Cold-Chain refrigeration (2°C to 8°C). This is critical because the conjugated proteins are highly sensitive; exposure to the Nigerian heat can break the chemical bond between the sugar and the protein, rendering the vaccine ineffective and leaving the patient vulnerable to "Type W" or "Type Y" outbreaks.

Important: This is a high-precision quadrivalent biological. The "Cold-Chain" Rule: You must transport and store Menactra in a refrigerator; do not freeze it. The "Hajj/Umrah" Note: For those traveling to Saudi Arabia, a quadrivalent (ACWY) conjugate vaccine like Menactra is a mandatory visa requirement and must be taken at least 10 days before travel. The "Long-Term" Benefit: Unlike older vaccines that only last 2–3 years, the "conjugate" technology in Menactra provides robust protection for 5 years or more.

Key Uses & Benefits

Menactra Quadrivalent Vaccines are primarily used for:

  • Meningitis A, C, W, Y Prevention: Providing broad-spectrum protection against the most common global strains

  • Sepsis Defense: Preventing "Meningococcemia" (blood poisoning), which can cause limb loss or death within 24 hours

  • Travel Immunization: Meeting international health requirements for pilgrims and cross-border travelers

  • Student Safety: Protecting adolescents entering boarding schools or university hostels (high-risk areas)

  • Outbreak Control: Providing rapid immunity during local "Meningitis Belt" seasonal clusters

  • Providing Superior Immune Memory: Training the body to remember the bacteria for many years

  • Offering a Lower Carrier State: Reducing the chance of the person "carrying" the bacteria in their throat and spreading it to others

Who Should Receive Menactra?

This vaccine is intended for:

  • Children and adolescents from 9 months to 55 years of age

  • Travelers to sub-Saharan Africa or the Middle East (especially during the dry season)

  • Individuals with "Asplenia" (no spleen) or specific immune deficiencies

Not recommended for: Infants under 9 months of age or adults over 55 years (though often given "off-label" to older travelers). It is strictly contraindicated for individuals with a history of a severe allergic reaction to a previous dose of any Meningococcal or Diphtheria toxoid vaccine. Use with extreme caution if you have ever had Guillain-Barré Syndrome (GBS). Consult our pharmacist if you have a high fever; wait until you recover before getting the shot. Consult your doctor if you are pregnant; while not a live vaccine, it is only given if the risk of infection is very high.

Suggested Clinical Usage

  • Administered via Intramuscular (IM) injection (0.5ml) into the deltoid (shoulder) or anterolateral thigh.

  • The "Dose" Rule: Children aged 9–23 months require two doses (3 months apart); those aged 2–55 years require only one dose.

  • The "Booster" Note: For those at continuous high risk, a booster dose is typically recommended every 5 years.

  • The "Wait" Tip: Menactra can be given at the same time as other vaccines (like Yellow Fever or Typhoid), but it should be injected into a different limb.

  • Consistency is Vital: If you are traveling, ensure your "Yellow Card" is stamped with the correct batch number and date by a certified professional.

  • The "Storage" Tip: Once taken out of the fridge, it must be used within a few hours; keep it in a validated vaccine carrier with ice packs during transport.

Common Side Effects

Menactra is generally well-tolerated, but it triggers a strong immune response, potentially causing:

  • Injection Site Reactions: Redness, soreness, and a slight hard lump at the needle site (very common)

  • Mild fever (usually below 38.5°C) and fatigue for 24–48 hours

  • Headache and Muscle Aches: A general "heavy" feeling in the arm or body

  • Loss of appetite or irritability in young children

  • Rare but serious: Anaphylaxis (severe allergic reaction immediately after the shot)

  • Rare: A temporary fainting spell (syncope) in teenagers after the needle prick

Seek medical advice immediately if the patient develops difficulty breathing, a high fever that won't come down, or unusual weakness in the legs.

Manufacturer

Sanofi Pasteur (USA/France) – A world leader in immunology, ensuring that every vial of Menactra meets the highest international standards for conjugate purity and strain coverage.

Why Buy Menactra from Sanlive Pharmacy?

  • 100% authentic vaccine—guaranteed original Sanofi stock with verified NAFDAC registration.

  • Guaranteed high-quality storage in Medical Grade Refrigerators with 24/7 power backup to ensure antigen stability.

  • Professional counseling from licensed pharmacists on "Travel Health" and "School Entry" requirements.

  • Secure delivery in temperature-controlled packaging to your home or clinic across Nigeria.

Frequently Asked Questions (FAQs)

Does this replace the "Meningitis A" (MenAfriVac) shot given in local clinics?

Yes, and it offers more. While the local "Men A" shot only covers one strain, Menactra covers four (A, C, W, Y). In modern environments, Group W and Group Y are becoming more common, so Menactra provides a much wider shield.

Why do I need a "Yellow Card" stamp?

Many countries, including Saudi Arabia for Hajj, require legal proof of vaccination. A stamp from a registered facility like Sanlive Pharmacy ensures your vaccination is recognized by international immigration and health authorities.

Can I get this if I have "Sickle Cell"?

Yes. In fact, it is highly recommended. People with Sickle Cell are at a much higher risk of severe bacterial meningitis, and the "Conjugate" protection of Menactra is vital for their safety.

Where can I purchase Menactra in Nigeria?

You can fill your clinical or travel immunization request for verified Menactra at Sanlive Pharmacy & Stores for guaranteed product integrity and professional neurological health support.

No reviews yet.

Login to write a review.